InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolys...
Pengadilan Israel tolak permohonan injunksi sementara terhadap InMode
INMD: Q2 2026 saw stable revenue, margin pressure, and strong cash flow with robust Asia growth
InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 | INMD Stock News
Systematic Financial Management LP Increases Stock Holdings in InMode Ltd. $INMD
InMode issues shareholder letter on special committee review of acquisition proposals
Analyst Maintains Hold on InMode Amid Takeover Uncertainty and Limited Profitability Visibility